Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001062993-25-000932
Filing Date
2025-01-21
Accepted
2025-01-21 11:42:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 12330
2 EXHIBIT 6 exhibit6.htm EX-99.6 74072
3 GRAPHIC exhibit6xu001.jpg GRAPHIC 4581
  Complete submission text file 0001062993-25-000932.txt   94590
Mailing Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174
Business Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174 212-542-4635
Saba Capital Management, L.P. (Filed by) CIK: 0001510281 (see all company filings)

EIN.: 800361690 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 800 882 0052
BlackRock Health Sciences Term Trust (Subject) CIK: 0001785971 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92129 | Film No.: 25541255